NYSE: PFE - PFIZER

Yield per half year: -5.92%
Sector: Healthcare

Share chart PFIZER


About

Pfizer Inc. обнаруживает, разрабатывает, производит, продает, распространяет и продает биофармацевтические продукты по всему миру. Он предлагает лекарства и вакцины в различных терапевтических областях, включая сердечно-сосудистый метаболизм и обезболивание, под торговыми марками Eliquis, Chantix / Champix и Premarin; биопрепараты, малые молекулы, иммунотерапевтические препараты и биоаналоги под брендами Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena и Braftovi; стерильные инъекционные и противоинфекционные препараты торговых марок Сульперазон, Медрол, Зитромакс, Вифенд и Панзига.

More details
Компания также предоставляет лекарства и вакцины в различных терапевтических областях, таких как пневмококковая инфекция, менингококковая инфекция, клещевой энцефалит и COVID-19 в рамках Prevnar 13 / Prevenar 13 (для детей / взрослых), Nimenrix, FSME / IMMUN-TicoVac, Труменба и бренды вакцины Pfizer-BioNTech COVID-19; биоаналоги для лечения хронических иммунных и воспалительных заболеваний под торговыми марками Xeljanz, Enbrel, Inflectra и Eucrisa / Staquis; а также амилоидоз, гемофилия и эндокринные заболевания под брендами Vyndaqel / Vyndamax, BeneFIX и Genotropin. Кроме того, компания занимается контрактным производством. Он обслуживает оптовиков, розничных торговцев, больницы, клиники, государственные учреждения, аптеки и офисы индивидуальных поставщиков, а также центры контроля и профилактики заболеваний. Компания имеет соглашения о сотрудничестве с Bristol-Myers Squibb Company; Астеллас Фарма США, Инк .; Myovant Sciences Ltd .; Akcea Therapeutics, Inc; Merck KGaA; Валнева С.Е .; BioNTech SE; и Syapse, Inc. Pfizer Inc. была основана в 1849 году, ее штаб-квартира находится в Нью-Йорке, штат Нью-Йорк.


Main settings

Цена ао 27.87
P/E 12.86
P/S 4.04
P/BV 3.3
EV/EBITDA 13.17
Дивиденд ао 1.64
Див.доход ао 4.49
EBITDA 19.75
Сайт http://www.pfizer.com
Число акций ао 5.709 млрд
Выручка 51.75
ISIN US7170811035
Change price per day: -2.01% (28.88)
Change price per week: -0.9104% (28.56)
Change price per month: +11.42% (25.4)
Change price per 3 month: +5.24% (26.89)
Change price per half year: -5.92% (30.08)
Change price per year: -25.86% (38.17)
Change price per 3 year: -35.59% (43.94)
Change price per 5 year: -26.61% (38.56)
Change price per year to date: -1.702% (28.79)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 4.04 6
P/BV 3.3 8
P/E 12.86 1
EV/EBITDA 13.17 5
Total:

Efficiency

Title Value Grade
ROA, % 1.0002 1
ROE, % 2.29 1
Total:

Dividends

Title Value Grade
Div yield, % 5.67 10
DSI 0.93 9
Total:

Debt

Title Value Grade
Debt/EBITDA 7.13 1
Total:

Growth impulse

Title Value Grade
Profit growth, % 61.82 10
Share price growth, % 9.11 2
Dividend growth, % 5.71 1
Total:

Dividends

Dividends, % Dividends Result of period Buy before Register closing date Payment before
1.45% 0.42 I кв. 2024 07.05.2024 09.05.2024 24.05.2024
1.65% 0.42 IV кв. 2023 23.01.2024 25.01.2024 09.02.2024
1.36% 0.41 III кв. 2023 07.11.2023 09.11.2023 24.11.2023
1.13% 0.41 II кв. 2023 25.07.2023 27.07.2023 11.08.2023
0.86% 0.41 IV кв. 2022 24.01.2023 26.01.2023 10.02.2023
0.87% 0.4 III кв. 2022 01.11.2022 03.11.2022 18.11.2022
0.77% 0.4 II кв. 2022 26.07.2022 28.07.2022 12.08.2022
0.8% 0.4 IV кв. 2021 25.01.2022 27.01.2022 11.02.2022
0.7% 0.39 III кв. 2021 02.11.2021 04.11.2021 19.11.2021
0.88% 0.39 II кв. 2021 27.07.2021 29.07.2021 13.08.2021
0.94% 0.38 I кв. 2021 04.05.2021 06.05.2021 21.05.2021
1.03% 0.38 IV кв. 2020 26.01.2021 28.01.2021 12.02.2021

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
25.02.2023 28.02.2023 Hwang Angela
President, Global Biopharma
Buy 22.89 464 049 20273 0 0 link
25.02.2023 28.02.2023 DAMICO JENNIFER B.
SVP & Controller
Buy 22.89 255 224 11150 0 0 link
25.02.2023 28.02.2023 McDermott Michael
Executive Vice President
Buy 22.89 324 534 14178 0 0 link
22.02.2023 24.02.2023 DAMICO JENNIFER B.
SVP & Controller
Buy 30.17 315 458 10456 0 0 link
22.02.2023 24.02.2023 JOHNSON RADY A
Executive Vice President
Buy 30.17 952 105 31558 0 0 link
16.12.2022 16.12.2022 BOURLA ALBERT
Chairman & CEO
Buy 27.25 6 058 440 222328 0 0 link
14.12.2022 16.12.2022 LANKLER DOUGLAS M
Executive Vice President
Buy 26.29 2 672 590 101658 0 0 link
23.02.2022 25.02.2022 DAMICO JENNIFER B.
SVP & Controller
Buy 27.34 321 190 11748 0 0 link
23.02.2022 25.02.2022 DAMELIO FRANK A
Executive Vice President
Buy 27.34 4 204 590 153789 0 0 link
23.02.2022 25.02.2022 Hwang Angela
Group President
Buy 27.34 583 955 21359 0 0 link
17.12.2021 21.12.2021 BOURLA ALBERT
Chairman & CEO
Buy 26.73 3 289 260 123055 0 0 link
17.12.2021 21.12.2021 Dolsten Mikael
President R&D
Buy 30.17 2 147 710 71187 0 0 link
11.11.2021 12.11.2021 YOUNG JOHN D
Group President
Sale 50.06 7 509 000 150000 0 0 link
30.07.2021 02.08.2021 DAMICO JENNIFER B.
SVP & Controller
Sale 42.86 107 150 2500 0 0 link

Main owners

Institutions Volume Share, %
Vanguard Group Inc 506517466 8.95
Blackrock Inc. 432503754 7.64
State Street Corporation 287482006 5.08
Wellington Management Group, LLP 239209768 4.22
Capital World Investors 173394272 3.06
Geode Capital Management, LLC 109534217 1.93
Charles Schwab Investment Management, Inc. 104246432 1.84
Morgan Stanley 82106536 1.45
Norges Bank Investment Management 73981480 1.31
Massachusetts Financial Services Co. 68506441 1.21

Contained in ETF

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Morningstar Large-Cap Value ETF 2.09 46.07 2.71
John Hancock Multifactor Healthcare ETF 4.93 29.34 1.62
First Trust Value Line 100 ETF 0.63 4.14 1.17
Direxion S&P 500 High minus Low Quality ETF 2.76 27.31 14.09
WisdomTree BioRevolution Fund 1.9
Apex Healthcare ETF 3.92
Nationwide Maximum Diversification U.S. Core Equity ETF 1.54 26.65 1.58
Global Beta Low Beta ETF 2.42 19.88 2.09
Franklin LibertyQ Global Dividend ETF 2.15 30.37 2.67
Franklin LibertyQ Global Equity ETF 1.05 25.84 2.05
FlexShares Quality Dividend Dynamic Index Fund 2.13 33.57 2.42
iShares Factors US Value Style ETF 1.71 42.34 2.98
ROC ETF 2.21 0.07
IQ U.S. Large Cap R&D Leaders ETF 2.22 1.21
IQ Global Equity R&D Leaders ETF 1.19 1.96
FinEx USA UCITS ETF 0.37 54.54
FinEx RUB GLOBAL EQUITY UC ETF 0.09 48.06
FinEx USD GLOBAL EQUITY UC ETF 0.09 37.73
IQ Healthy Hearts ETF 4.89 1.17
First Trust Morningstar Dividend Leaders Index Fund 7.6 31.04 4.33
iShares Global Healthcare ETF 2.12 23.74 1.31
VanEck Pharmaceutical ETF 4.7 21.73 1.74
Schwab US Dividend Equity ETF 4.08 39.17 3.36
Health Care Select Sector SPDR Fund 2.98 28.02 1.51
iShares Select Dividend ETF 1.72 45.56 3.56
Vanguard Health Care ETF 2.46 29.53 1.30
iShares MSCI USA Value Factor ETF 2.43 41.01 2.48
iShares U.S. Healthcare ETF 2.88 29.01 3.37
Fidelity MSCI Health Care Index ETF 2.63 29.23 1.32
Invesco S&P 500® High Dividend Low Volatility ETF 2.27 35.73 4.15
Invesco High Yield Equity Dividend Achievers™ ETF 2.52 42.77 4.94
Invesco S&P 500 Equal Weight Health Care ETF 1.68 0.63
Invesco S&P Ultra Dividend Revenue ETF 5.33 50.70 3.92
iShares U.S. Pharmaceuticals ETF 4.89 19.17 2.88
Invesco Pharmaceuticals ETF 5.91 28.63 0.91
Direxion Daily Healthcare Bull 3x Shares 2.62 93.37 1.62
SPDR S&P Pharmaceuticals ETF 4.96 11.67 1.43
Humankind US Stock ETF 1.57 1.61
WisdomTree Global High Dividend Fund 1.62 28.71 4.17
ProShares Ultra Health Care 2.2 61.62 0.33
Xtrackers Russell 1000 US Quality at a Reasonable Price ETF 1.47 34.86 1.26
PIMCO RAFI ESG U.S. ETF 1.72 39.15 1.76
KFA Value Line Dynamic Dividend Equity Index ETF 1.95 2.62
First Trust Nasdaq Pharmaceuticals ETF 8.17 10.11 1.41
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 4.23 21.40 2.15
Harbor Health Care ETF 4.77 1.83

Similar companies



Company management

Head Job title Payment Year of birth
Ms. Jennifer B. Damico Senior VP, Controller & Principal Accounting Officer N/A 1968 (56 years)
Ms. Lidia L. Fonseca Executive VP and Chief Digital & Technology Officer N/A 1969 (55 years)
Mr. Douglas M. Lankler Executive VP & General Counsel 1.76M 1966 (58 years)
Dr. Mikael Dolsten M.D., Ph.D. Chief Scientific Officer and President of Research & Development 2.41M 1958 (66 years)
Mr. David M. Denton Chief Financial Officer & Executive VP 1.75M 1965 (59 years)
Mr. Rady A. Johnson Executive VP and Chief Compliance, Quality & Risk Officer N/A 1962 (62 years)
Dr. Albert Bourla D.V.M., Ph.D. Chairman of the Board & CEO 4.05M 1962 (62 years)
Ms. Francesca M. DeMartino Chief Investor Relations Officer N/A
Mr. Andreas J. Panayiotou Global Chief Marketing Officer N/A
Mr. Aamir Malik Executive VP & Chief U.S. Commercial Officer 1.89M 1976 (48 years)

About company

Address: United States, New York, NY , 235 East 42nd Street - open in Google maps, open in Yandex maps
Website: http://www.pfizer.com
Phone: +212 733 2323